Atara Biotherapeutics, Inc. (ATRA) — Institutional Holders, Q2 2026

36 institutional investment managers reported a ATRA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $51.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ATRA in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

4

Added to

12

Trimmed

8

Sold out

2

Biggest buyers

  1. EcoR1 CapitalAdded · +1,452,407 sh+$16.7M
  2. Point72 Asset Management, L.P.Added · +493,454 sh+$5.7M
  3. ADAGE CAPITAL PARTNERS GP, L.L.C.Added · +150,000 sh+$1.7M
  4. VANGUARD CAPITAL MANAGEMENTAdded · +29,185 sh+$335.0K
  5. XTX Topco LtdNew · +15,303 sh+$175.7K

Biggest sellers

  1. ACADIAN ASSET MANAGEMENTTrimmed · -92,065 sh-$1.1M
  2. MACKENZIE FINANCIALTrimmed · -80,371 sh-$922.7K
  3. UBS Group AGTrimmed · -46,091 sh-$529.1K
  4. MILLENNIUM MANAGEMENTTrimmed · -35,009 sh-$401.9K
  5. BRIDGEWAY CAPITAL MANAGEMENTTrimmed · -18,691 sh-$214.6K

ATRA 13F holders ranked 1–36 of 36

Institutional investors reporting a position in Atara Biotherapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
EcoR1 Capital#1 · 1,552,000 sh$17.8M+1458.3%
ADAGE CAPITAL PARTNERS GP, L.L.C.#2 · 850,000 sh$9.8M+21.4%
Point72 Asset Management, L.P.#3 · 687,718 sh$7.9M+254.0%
Redmile Group#4 · 441,701 sh$5.1M0.0%
VANGUARD CAPITAL MANAGEMENT#5 · 247,047 sh$2.8M+13.4%
MACKENZIE FINANCIAL#6 · 233,249 sh$2.7M-25.6%
BlackRock#7 · 84,455 sh$969.5K+6.9%
GEODE CAPITAL MANAGEMENT#8 · 75,128 sh$862.9K+13.6%
STALEY CAPITAL ADVISERS#9 · 50,000 sh$574.0K0.0%
VANGUARD FIDUCIARY#10 · 43,036 sh$494.1K+28.0%
ACADIAN ASSET MANAGEMENT#11 · 38,845 sh$444.0K-70.3%
JANE STREET GROUP#12 · 30,345 sh$348.4K-10.4%
STATE STREET#13 · 26,453 sh$303.7K0.0%
NORTHERN#14 · 16,591 sh$190.5K+34.4%
FMR#15 · 16,238 sh$186.4K0.0%
XTX Topco Ltd#16 · 15,303 sh$175.7KNew
BRIDGEWAY CAPITAL MANAGEMENT#17 · 14,000 sh$160.7K-57.2%
MILLENNIUM MANAGEMENT#18 · 12,680 sh$145.6K-73.4%
CITADEL ADVISORS#19 · 10,159 sh$116.6KNew
MORGAN STANLEY#20 · 9,178 sh$105.4K+0.1%
ROYAL BANK OF CANADA#21 · 4,743 sh$55.0K+9.8%
UBS Group AG#22 · 3,979 sh$45.7K-92.1%
Vanguard Global Advisers#23 · 1,456 sh$16.7K0.0%
SBI Securities , Ltd.#24 · 1,404 sh$16.1K-10.8%
JONES FINANCIAL COMPANIES LLLP#25 · 803 sh$8.4K+14.2%
Caitong International Asset Management , Ltd#26 · 311 sh$3.6KNew
BARCLAYS PLC#27 · 304 sh$3.5KNew
Banque Transatlantique SA#28 · 176 sh$3.1K0.0%
WELLS FARGO & COMPANY#29 · 251 sh$2.9K0.0%
JPMORGAN CHASE#30 · 216 sh$2.4K0.0%
CITIGROUP#31 · 97 sh$1.1K+9600.0%
BNP PARIBAS FINANCIAL MARKETS#32 · 46 sh$528.00-20.7%
PlanVest Financial#33 · 28 sh$321.000.0%
KERR FINANCIAL PLANNING#34 · 24 sh$276.000.0%
OSAIC#35 · 10 sh$114.000.0%
Rockefeller Capital Management L.P.#36 · 8 sh$92.000.0%

Funds that sold out of ATRA in Q2 2026 (2)

Held ATRA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held ATRA in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
RHUMBLINE ADVISERS175 sh$827.00
Western Wealth Management1 sh$5.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.